Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2617 - 2624 of 12099 results
TCPA Regulatory Update — Chairwoman Rosenworcel Circulates Declaratory Ruling on Ringless Voicemails
February 22, 2022| Article| Viewpoint
A Business Deal Could Kill Your Right to Challenge a Patent’s Validity
February 22, 2022| Blog| Viewpoint
EXCLUSIVE RIGHTS: Intellectual Property — Domestic Industry at the ITC – The Commission Has Set a Positive Trend
February 18, 2022| Podcast| Viewpoint
(Updated) Congress Ends Mandatory Arbitration of Sexual Harassment and Sexual Assault Claims
February 18, 2022| Blog| Viewpoint
Facebook to Pay $90 Million to Settle Data Privacy Lawsuit
February 18, 2022| Blog| Viewpoint
Minimizing Stockholder Litigation Risks
February 18, 2022| Blog| Viewpoint
DOJ Tells Cybercriminals, “If you continue to come for us we will come for you” and Warns Companies to Keep Their “Cyber Shields Up”
February 18, 2022| Blog| Viewpoint
D. Del. Says ANDA Specification Trumps All Else in Infringement Analysis
February 17, 2022| Blog| Viewpoint
News & Press Releases
Mintz Advises on Equillium, Inc.'s up to $50 Million PIPE
August 15, 2025
Mintz advised the lead placement agent in connection with an up to $50 million private placement by Equillium, Inc. The PIPE was comprised of (i) an initial upfront closing of approximately $30 million in gross proceeds in exchange for approximately 52.6 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), and (ii) the potential for up to an additional $20 million in gross proceeds in exchange for up to approximately 35.1 million shares of common stock (or, for certain investors, pre-funded warrants in lieu of common stock), subject to achieving specified milestones related to clinical study initiation and share price.
Eleven Mintz Attorneys Named to 2025 IAM Strategy 300 List of Leading IP Strategists
August 14, 2025
Mintz announces that eleven of its attorneys have been named to the 2025 IAM Strategy 300: The World's Leading IP Strategists list, which recognizes individuals for their trailblazing work in developing and implementing strategies that maximize the value of intellectual property portfolios.
ESG-Focused Activism Persists Despite Proxy Curbs
August 12, 2025
Law360 published an article written by Mintz Members Jacob Hupart, Ellen Shapiro, and Associate Will McKitterick about the role ESG considerations continue to play in shareholder activism and proxy battles. The article also examines how recent regulatory and political developments have raised the bar for ESG-related proposals, influencing both strategy and outcomes.
Events
Podcasts
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|